IRIS Accounts Production v23.3.0.418 12545426 director 1.4.22 31.3.23 31.3.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure125454262022-03-31125454262023-03-31125454262022-04-012023-03-31125454262021-03-31125454262021-04-012022-03-31125454262022-03-3112545426ns16:EnglandWales2022-04-012023-03-3112545426ns15:PoundSterling2022-04-012023-03-3112545426ns11:Director12022-04-012023-03-3112545426ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3112545426ns11:SmallEntities2022-04-012023-03-3112545426ns11:Audited2022-04-012023-03-3112545426ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3112545426ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-3112545426ns11:FullAccounts2022-04-012023-03-3112545426ns11:RegisteredOffice2022-04-012023-03-3112545426ns6:CurrentFinancialInstruments2023-03-3112545426ns6:CurrentFinancialInstruments2022-03-3112545426ns6:ShareCapital2023-03-3112545426ns6:ShareCapital2022-03-3112545426ns6:RetainedEarningsAccumulatedLosses2023-03-3112545426ns6:RetainedEarningsAccumulatedLosses2022-03-3112545426ns6:ShareCapital2021-03-3112545426ns6:RetainedEarningsAccumulatedLosses2021-03-3112545426ns6:RetainedEarningsAccumulatedLosses2021-04-012022-03-3112545426ns6:RetainedEarningsAccumulatedLosses2022-04-012023-03-3112545426ns6:PlantMachinery2022-04-012023-03-3112545426ns6:OwnedAssets2022-04-012023-03-3112545426ns6:OwnedAssets2021-04-012022-03-3112545426ns6:ComputerEquipment2022-03-3112545426ns6:ComputerEquipment2022-04-012023-03-3112545426ns6:ComputerEquipment2023-03-3112545426ns6:ComputerEquipment2022-03-3112545426ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3112545426ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3112545426ns6:RetainedEarningsAccumulatedLosses2022-03-311254542612022-04-012023-03-31
REGISTERED NUMBER: 12545426 (England and Wales)















AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

FOR

SIRIONLABS LIMITED

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023










Page

Company Information 1

Report of the Independent Auditors 2

Income Statement 5

Balance Sheet 6

Statement of Changes in Equity 7

Notes to the Financial Statements 8


SIRIONLABS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2023







DIRECTOR: Ajay Agrawal



REGISTERED OFFICE: 2 Churchill Court
58 Station Road
North Harrow
Middlesex
HA2 7SA



REGISTERED NUMBER: 12545426 (England and Wales)



AUDITORS: Smartax Limited
Chartered Certified Accountants and
Statutory Auditors
38 Station Road
Harrow
Middlesex
HA2 7SE



BANKERS: ICICI
ICICI Bank UK PLC
1 Thomas More Square
London
E1W 1YN



ACCOUNTANTS: Auctus Accountants Ltd
2 Churchill Court
58 Station Road
North Harrow
HA2 7SA

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
SIRIONLABS LIMITED


Although the company is only required to file a Balance Sheet, requires the accompanying Report of the Auditors to be a copy of our report to the members on the company's full Financial Statements and Report of the Director. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director, referred to in the copy of our Report of the Auditors, are not required to be filed with the Registrar of Companies.

Opinion
We have audited the financial statements of SirionLabs Limited (the 'company') for the year ended 31 March 2023 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 March 2023 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

The impact of uncertainties due to COVID-19 and Britain exiting the European Union on our audit
Uncertainties related to the effects of COVID-19 and Brexit are relevant to understanding our audit of the accounts.
All audits assess and challenge the reasonableness of estimates made by the directors, such as recoverability of investments, intangible assets and related disclosures and the appropriateness of the going concern basis of preparation of the accounts. All of these depend on assessments of the future economic environment and the company's future prospects and performance.

The COVID-19 pandemic has had an unprecedented impact upon the worldwide economy. At the date of this report, the full range of possible effects upon companies cannot be estimated or assessed due to the current levels of uncertainty around government and consumer responses to what might happen.
Brexit is one of the most significant economic events of the UK, and at the date of this report its effects are subject to unprecedented levels of uncertainty of outcomes, with the full range of possible effects unknown.

We applied a standard firm-wide approach in response to these uncertainties when assessing the company's future prospects and performance. No audit should be expected to predict the unknown factors or all possible future implications for a company and this is particularly the case in relation to COVID-19 and Brexit.

Material uncertainty related to going concern.
We draw attention to Note 12, which indicates that the company is reliant on the financial support from its parent company. As stated in Note 12, these conditions, along with other matters as set forth in Note 10, indicate that a material uncertainty exists that may cast significant doubt on the company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
SIRIONLABS LIMITED


Other information
The director is responsible for the other information. The other information comprises the information in the Report of the Director, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Report of the Director for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Report of the Director has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Director.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of director's remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit; or
- the director was not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption from the requirement to prepare a Strategic Report or in preparing the Report of the Director.

Responsibilities of director
As explained more fully in the Statement of Director's Responsibilities set out on page one, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
SIRIONLABS LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We gained an understanding of the legal and regulatory framework applicable to the company and the industry in which it operates, and considered the risk of acts by the company that were contrary to applicable laws and regulations, including fraud. Our audit procedures were designed to respond to the risk, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

We focused on laws and regulations that could give rise to a material misstatement in the financial statements, including, but not limited to, financial reporting legislation, the Companies Act 2006, distributable profits legislation and UK pensions and tax legislation. We assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial statement items. Our tests included agreeing the financial statement disclosures to underlying supporting documentation and enquiries with management regarding correspondence with regulators and tax authorities.

There are inherent limitations in the audit procedures described above and, the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it and therefore we have communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indication of fraud or non-compliance with laws and regulations throughout the audit.

We evaluated management's incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of override of controls), and determined that the principal risks were related to management bias in accounting estimates. We addressed the risk of management override of internal controls through testing journals. We evaluated whether there was evidence of bias by the directors in accounting estimates that represented a risk of material misstatement due to fraud. We challenged assumptions and judgements made by management in any significant accounting estimates.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




S Rajan CTA FCCA ACA (Senior Statutory Auditor)
for and on behalf of Smartax Limited
Chartered Certified Accountants and
Statutory Auditors
38 Station Road
Harrow
Middlesex
HA2 7SE

3 November 2023

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

INCOME STATEMENT
FOR THE YEAR ENDED 31 MARCH 2023

31.3.23 31.3.22
Notes £    £   

TURNOVER 3,616,003 1,219,314

Administrative expenses (3,587,052 ) (1,191,857 )
OPERATING PROFIT and
PROFIT BEFORE TAXATION 28,951 27,457

Tax on profit 5 (2,374 ) (4,109 )
PROFIT FOR THE FINANCIAL YEAR 26,577 23,348

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

BALANCE SHEET
31 MARCH 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 6 19,828 8,699

CURRENT ASSETS
Debtors 7 263,163 168,722
Cash at bank 293,539 24,922
556,702 193,644
CREDITORS
Amounts falling due within one year 8 496,668 149,058
NET CURRENT ASSETS 60,034 44,586
TOTAL ASSETS LESS CURRENT
LIABILITIES

79,862

53,285

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 9 78,862 52,285
79,862 53,285

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 3 November 2023 and were signed by:





Ajay Agrawal - Director


SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2023

Called up
share Retained Total
capital earnings equity
£    £    £   

Balance at 1 April 2021 1,000 28,937 29,937

Changes in equity
Profit for the year - 23,348 23,348
Total comprehensive income - 23,348 23,348
Balance at 31 March 2022 1,000 52,285 53,285

Changes in equity
Profit for the year - 26,577 26,577
Total comprehensive income - 26,577 26,577
Balance at 31 March 2023 1,000 78,862 79,862

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023


1. STATUTORY INFORMATION

SirionLabs Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The accounts are prepared in sterling, which is the functional currency of the entity.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is generated from recharges to the parent company with an applied profit markup.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33.33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023


2. ACCOUNTING POLICIES - continued

Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 13 (2022 - 13 ) .

4. OPERATING PROFIT

The operating profit is stated after charging:

31.3.23 31.3.22
£    £   
Depreciation - owned assets 6,628 2,983
Auditors' remuneration 4,286 3,750

5. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
31.3.23 31.3.22
£    £   
Current tax:
UK corporation tax 2,374 4,109
Tax on profit 2,374 4,109

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023


6. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2022 12,595
Additions 17,757
At 31 March 2023 30,352
DEPRECIATION
At 1 April 2022 3,896
Charge for year 6,628
At 31 March 2023 10,524
NET BOOK VALUE
At 31 March 2023 19,828
At 31 March 2022 8,699

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Amounts owed by group undertakings 215,971 152,946
Other debtors 47,192 15,776
263,163 168,722

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade creditors 8,294 -
Taxation and social security 98,165 51,079
Other creditors 390,209 97,979
496,668 149,058

9. RESERVES
Retained
earnings
£   

At 1 April 2022 52,285
Profit for the year 26,577
At 31 March 2023 78,862

10. PENSION COMMITMENTS

The amount recognised in the profit and loss as an expense in relation to defined contribution plans was £78,257 (2022 - £5,171). As at the period end contributions totalling £6,179 (2022 - £Nil) were payable.

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023


11. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial reporting Standard applicable in the UK and Republic of Ireland', not to disclose transactions in the year between wholly owned group undertakings.

12. GOING CONCERN

The company derives its revenue on a cost plus basis from the parent company SirionLabs PTE. LTD. As such it is entirely reliant on the parent company for its financial support. The directors have reviewed the current results of the company together with the financial position of the parent company, and after making enquiries will continue to receive the necessary support from SirionLabs PTE. LTD for the foreseeable future and at least for twelve months from the date of signing.

Accordingly, the directors continue to adopt the going concern basis in preparing the accounts. As such the accounts do not contain adjustments that would be required if the company was unable to continue as a going concern.

13. POST BALANCE SHEET EVENTS

Other than those described below, no matters or circumstances have arisen since the year-end date that
significantly affect, or are likely to affect the operations, results or state of affairs of the Company for the
foreseeable future.

The ongoing global Covid-19 pandemic has impacted, and may continue to impact many aspects of the
Company's business and operations.

The Covid 19 pandemic has been declared as a global emergency. In response to this, many countries have put in place, and will continue to put in place, quarantines, executive orders, physical distancing requirements, shelter in place orders, and similar government orders and restrictions in order to control the spread of the disease. Such orders or restrictions have resulted in business closures, work stoppages, slowdowns and delays, work from home policies, travel restrictions, and cancellation and postponement of events, among other effects that could impact the Company's operations.

The Company has taken and may need to take further actions that alter operations as required by government or local authorities, or which the company determines is in its best interests. Furthermore, the company may decide to postpone or cancel planned investments in the business or response to changes in the business as a result of the spread of Covid-19, which could lead to a substantial change in the business and its structure.

The global impact of Covid-19 continues to rapidly evolve, and the company will continue to monitor the situation closely. The ultimate impact of the Covid-19 pandemic or a similar health epidemic is highly uncertain and subject to change. The Company does not yet know the full extent of the potential delays or impacts on the Company's business, operations, or the global economy as a whole. While the spread of Covid-19 may eventually be contained or mitigated, there are no guarantees that the outbreak of this or any other widespread epidemics will not occur, or that the global economy will recover, either of which could substantially change the Company's business.

14. ULTIMATE CONTROLLING PARTY

The immediate parent company is SirionLabs PTE. LTD, a company registered in Singapore whose registered office is situated at 120, Robinson road, 03-12 Singapore, 068914.


In the opinion of the directors, there is no ultimate controlling party for the company.